Product
Drug intervention
1 clinical trial
1 indication
Indication
NSCLCClinical trial
Toripalimab Combined With Pemetrexed Plus Carboplatin for Treatment of Recurrent or Advanced Non-small-cell Lung Cancer With EGFR-mutation Positive and T790M Negative After Progression on EGFR-TKI Treatment：a Multi-center, Single Arm Phase II StudyStatus: Completed, Estimated PCD: 2022-08-12